Evidence map›Paper›PMID 36746627›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2023

Targeting Astrocyte Signaling Alleviates Cerebrovascular and Synaptic Function Deficits in a Diet-Based Mouse Model of Small Cerebral Vessel Disease.

Pradoldej Sompol, Jenna L Gollihue, Blaine E Weiss, Ruei-Lung Lin, Sami L Case, Susan D Kraner, Erica M Weekman, John C Gant, Colin B Rogers, Dana M Niedowicz and 7 more

Open access · hybridFull text read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Vascular contribution to cognitive impairment and dementia (VCID): proceedings of 2025 workshop of the Jackson Laboratory.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. The Impact of Overexpression of the Mouse Ortholog ofBiological psychiatry global open science · 2025
    Article
  17. Article
  18. Astrovascular decoupling in awake 5×FAD mice is associated with reduced astrocytic calcium.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  19. Article
  20. Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 2 countries.

Pradoldej SompolSanders-Brown Center on Aging.
Jenna L GollihueSanders-Brown Center on Aging.
Blaine E WeissSanders-Brown Center on Aging.
Ruei-Lung LinDepartments of Pharmacology and Nutritional Sciences.
Sami L CaseDepartments of Pharmacology and Nutritional Sciences.ORCID 0000-0002-1004-7246
Susan D KranerSanders-Brown Center on Aging.ORCID 0000-0002-1062-4007
Erica M WeekmanSanders-Brown Center on Aging.
John C GantSanders-Brown Center on Aging.
Colin B RogersSanders-Brown Center on Aging.
Dana M NiedowiczSanders-Brown Center on Aging.
Tiffany L SudduthSanders-Brown Center on Aging.
David K PowellNeuroscience.
Ai-Ling LinSanders-Brown Center on Aging.
Peter T NelsonSanders-Brown Center on Aging.
Olivier ThibaultSanders-Brown Center on Aging.
Donna M WilcockSanders-Brown Center on Aging.
Christopher M NorrisSanders-Brown Center on Aging cnorr2@uky.edu.
Nutrition 21 (United States) · USUniversity of Kentucky · US

Funding

Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
Strategies for Targeting Astrocyte Reactivity in Alzheimer's Disease and Related DementiasP01AG078116 · NIA · UNIVERSITY OF KENTUCKY · PI Christopher Mark Norris · 2022 to 2026
$25.0M
University of Kentucky Alzheimer's Disease Research CenterP30AG072946 · NIA · UNIVERSITY OF KENTUCKY · PI LINDA J VAN ELDIK · 2021 to 2026
$23.5M
Calcineurin and inflammatory signaling processes in aging and Alzheimer's DiseaseR01AG027297 · NIA · UNIVERSITY OF KENTUCKY · PI NORRIS, CHRISTOPHER MARK · 2006 to 2018
$3.2M
Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease ModelsR01AG058171 · NIA · WAYNE STATE UNIVERSITY · PI BENNETT, BRIAN M, BERKOWITZ, BRUCE A. · 2017 to 2021
$2.8M
Calcineurin and inflammatory signaling processes in aging and Alzheimer's DiseaseRF1AG027297 · NIA · UNIVERSITY OF KENTUCKY · PI NORRIS, CHRISTOPHER MARK · 2018 to 2022
$2.6M
Neurovascular astrocyte dysfunction in VCIDR01NS097722 · NINDS · UNIVERSITY OF KENTUCKY · PI WILCOCK, DONNA M · 2017 to 2021
$2.1M
Oxidative stress-induced vascular pathology and dysfunction in Alzheimer’s diseaseR21AG074146 · NIA · UNIVERSITY OF KENTUCKY · PI SOMPOL, PRADOLDEJ · 2022 to 2022
$421k
NCATS NIH HHS UL1 TR001998NIA NIH HHS P01 AG078116NIA NIH HHS P30 AG072946NIA NIH HHS R01 AG027297NIA NIH HHS R01 AG058171NIA NIH HHS R21 AG074146NIA NIH HHS RF1 AG027297NINDS NIH HHS R01 NS097722
6 · The paper itself

Abstract

Despite the indispensable role that astrocytes play in the neurovascular unit, few studies have investigated the functional impact of astrocyte signaling in cognitive decline and dementia related to vascular pathology. Diet-mediated induction of hyperhomocysteinemia (HHcy) recapitulates numerous features of vascular contributions to cognitive impairment and dementia (VCID). Here, we used astrocyte targeting approaches to evaluate astrocyte Ca

Indexed as

Alzheimer DiseaseHyperhomocysteinemiaAnimalsAstrocytesDietFemaleMaleMiceTranscription FactorsTranscription FactorsAlzheimer's diseaseCa2+neurovascular couplingreactive astrocytessynapsesvascular dementia

Identifiers

PMID36746627
PMCPMC10010459
OpenAlexW4319303492

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read59
identifiers read3
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.